113 related articles for article (PubMed ID: 4007025)
1. Phase II study of elliptinium in metastatic soft tissue sarcoma.
Somers R; Rouësse J; van Oosterom A; Thomas D
Eur J Cancer Clin Oncol; 1985 May; 21(5):591-3. PubMed ID: 4007025
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of elliptinium in advanced breast cancer.
Rouësse JG; Le Chevalier T; Caille P; Mondesir JM; Sancho-Garnier H; May-Levin F; Spielmann M; De Jager R; Amiel JL
Cancer Treat Rep; 1985 Jun; 69(6):707-8. PubMed ID: 4016774
[TBL] [Abstract][Full Text] [Related]
3. Elliptinium acetate in metastatic breast cancer--a phase II study.
Buzdar AU; Hortobagyi GN; Esparza LT; Holmes FA; Ro JS; Fraschini G; Lichtiger B
Oncology; 1990; 47(2):101-4. PubMed ID: 2314820
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of elliptinium in advanced renal cell carcinoma.
Caillé P; Mondesir JM; Droz JP; Kerbrat P; Goodman A; Ducret JP; Theodore C; Spielman M; Rouëssé J; Amiel JL
Cancer Treat Rep; 1985; 69(7-8):901-2. PubMed ID: 4016798
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium).
Einzig AI; Gralla RJ; Leyland-Jones BR; Kelsen DP; Cibas I; Lewis E; Greenberg E
Cancer Invest; 1985; 3(3):235-41. PubMed ID: 4005651
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial with high-dose elliptinium acetate in metastatic renal cell carcinoma.
Piot G; Droz JP; Theodore C; Ghosn M; Rouëssé J; Amiel JL
Oncology; 1988; 45(5):371-2. PubMed ID: 3412745
[TBL] [Abstract][Full Text] [Related]
7. A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma. An Illinois Cancer Center Study.
Gradishar WJ; Vogelzang NJ; Kilton LJ; Leibach SJ; Rademaker AW; French S; Benson AB
Invest New Drugs; 1995; 13(2):171-4. PubMed ID: 8617582
[TBL] [Abstract][Full Text] [Related]
8. [Failure of elliptinium acetate in the treatment of unresectable hepatocarcinoma (phase II trial)].
Rougier P; Ychou M; Droz JP
Bull Cancer; 1988; 75(10):979-81. PubMed ID: 2851337
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of doxorubicin, ifosfamide, and dacarbazine plus amphotericin B in the treatment of metastatic soft tissue sarcomas. A pilot study.
González-Manzano R; Vieitez JM; Tangco E; Fernandez de Alava E; Herranz P; Garcia-Foncillas J
Am J Clin Oncol; 1993 Aug; 16(4):332-7. PubMed ID: 8328412
[TBL] [Abstract][Full Text] [Related]
10. Phase II evaluation of chlorozotocin in metastatic sarcomas.
Presant CA; Bartolucci AA
Med Pediatr Oncol; 1984; 12(1):25-7. PubMed ID: 6230516
[TBL] [Abstract][Full Text] [Related]
11. Elliptinium: phase II study in advanced measurable breast cancer.
Treat J; Greenspan A; Rahman A; McCabe MS; Byrne PJ
Invest New Drugs; 1989 Jul; 7(2-3):231-4. PubMed ID: 2793378
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group.
Steward WP; Verweij J; Somers R; Blackledge G; Clavel M; Van Oosterom AT; Greifenberg B; Soedirman J; Thomas D; Van Glabbeke M
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S193-7. PubMed ID: 1795008
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast.
Sternberg CN; Yagoda A; Casper E; Scoppetuolo M; Scher HI
Anticancer Res; 1985; 5(4):415-7. PubMed ID: 4037737
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of 9-hydroxy-2N-methylellipticinium acetate.
Clarysse A; Brugarolas A; Siegenthaler P; Abele R; Cavalli F; de Jager R; Renard G; Rozencweig M; Hansen HH
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):243-7. PubMed ID: 6538489
[TBL] [Abstract][Full Text] [Related]
15. [N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
Rouesse J; Tursz T; Le Chevalier T; Huertas D; Amiel JL; Brule G; Callet B; Droz JP; Voisin PM; Sancho-Garnier H; Le Pecq JB; Paoletti C
Nouv Presse Med; 1981 May; 10(24):1997-9. PubMed ID: 7255136
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas.
Borden EC; Amato DA; Edmonson JH; Ritch PS; Shiraki M
Cancer; 1990 Sep; 66(5):862-7. PubMed ID: 2201431
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of metastatic renal cancer in adults with elliptinium acetate].
Amiel JL; Rouessé J; Droz JP; Caille P; Travagli JP; Théodore C; Le Chevalier T; Ducret JP; Bidart M; Garnier HS
Presse Med; 1984 Jun; 13(25):1555-7. PubMed ID: 6234539
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of piperazinedione in metastatic sarcoma.
Presant CA; Bartolucci AA
Am J Clin Oncol; 1982 Apr; 5(2):185-7. PubMed ID: 7046413
[TBL] [Abstract][Full Text] [Related]
19. N-(phosphonacetyl)-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group.
Bramwell V; Van Oosterom A; Mouridsen HT; Cheix F; Somers R; Thomas D; Rozencweig M
Eur J Cancer Clin Oncol; 1982 Jan; 18(1):81-4. PubMed ID: 6211362
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study.
Verweij J; Judson I; Steward W; Coleman R; Woll P; van Pottelsberghe C; van Glabbeke M; Mouridsen H
Eur J Cancer; 1994; 30A(6):842-3. PubMed ID: 7917546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
